Dr. Sarah E. Waldman, MD

Dr. Waldman practices at One Community Health - Sacramento in Sacramento, California.

Dr. Waldman's NPI, 1376832550, was assigned on March 29, 2011. Dr. Waldman graduated from UCSF School of Medicine in 2011. Dr. Waldman holds California license A125365.

Dr. Waldman's primary practice is One Community Health - Sacramento, at 1500 21st Street, Sacramento, CA 95811. The practice phone is (916) 443-3299.

Dr. Waldman's primary practice is One Community Health - Sacramento in Sacramento, California. Dr. Waldman is also affiliated with UC Davis Medical Center. The medical group on file is UC Davis Medical Group. Dmand AI also links Dr. Waldman to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Waldman practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Waldman's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Waldman is board certified in infectious disease by the American Board of Internal Medicine. Dr. Waldman is licensed in California.

Dmand AI lists hiv/aids among the conditions Dr. Waldman treats.

CMS data shows 125 Medicare services from Dr. Waldman across 4 procedure codes in 2024, for 71 Medicare patients. Medicare paid $8,335 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 71 Medicare patients who saw Dr. Waldman in 2024. The largest group is 65 to 74, with 36 patients. 72% of them have high blood pressure, and 70% have high cholesterol. 44% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Waldman's median patient age at 54, with 28% women.

In 2024, Dr. Waldman wrote 1,850 Medicare Part D claims for 153 patients. 59% of them were for generic drugs. CMS names the drug for 1,292 of them, across 51 drugs with 11 or more claims each, at $1,752,600 in total drug cost. In 2023, CMS named 2,566 claims across 77 drugs.

Dr. Waldman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Waldman as offering telehealth.

Dmand AI links 8 papers to Dr. Waldman, published from 2016 to 2022. 2021 was the busiest year, with 3. The most frequent topics are Coccidioides, Coccidioidomycosis and COVID-19. Dr. Waldman has published most often in Infect Control Hosp Epidemiol. Dr. Waldman's most frequent co-authors are Stuart H. Cohen, MD, Larissa Severine May, MD and Christian E. Sandrock, MD.

CMS Open Payments shows 34 general payments to Dr. Waldman from 4 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 58% of the total. Merck Sharp & Dohme Corporation paid the most, $945. It also lists 15 research payments totaling $1,108 in 2019.

Dr. Waldman graduated from UCSF School of Medicine in 2011.

Dr. Waldman is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.